Lugano Staging: An anatomical classification. Stage refers to the involvement of lymph node regions relative to the diaphragm.
Nodal Involvement (Clinical/PET)
Extra-nodal & Modifiers
Clinical Stage (Lugano Classification)
-A
Select nodes to determine stage.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
When to Use
Staging of Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL) using PET-CT or CT imaging.
Initial diagnostic workup to determine anatomical extent of disease.
Post-treatment assessment (end-of-treatment) to define remission.
Patient Population
Adult and pediatric patients with newly diagnosed or relapsed lymphoma.
Section 2
Formula & Logic
Anatomical Stages
Stage
Involvement
I
Single node region or extralymphatic site (IE)
II
Two or more node regions on the same side of the diaphragm
II Bulky
Stage II with "Bulky" disease (variously defined as > 7–10 cm)
III
Node regions on both sides of the diaphragm; includes spleen (IIIS)
IV
Diffuse or disseminated involvement of one or more extralymphatic organs (e.g., BM, liver, lung)
A / B Designation
Historically, "B" indicates constitutional symptoms (Fever, Night Sweats, Weight Loss), while "A" indicates their absence. In the Lugano 2014 updates, A/B persists mainly for Hodgkin Lymphoma; for NHL, clinical symptoms are documented but no longer change the stage I-IV for trial purposes.
Section 3
Pearls/Pitfalls
PET-CT is Standard
Lugano guidelines recommend PET-CT as the standard for FDG-avid lymphomas (HL, DLBCL, FL). For these lymphomas, a bone marrow biopsy is NOT required if PET-CT clearly shows marrow involvement.
Splenic Stage III
Involvement of the spleen is considered nodal involvement for the purposes of staging; thus, splenic disease below the diaphragm in a patient with cervical nodes above the diaphragm is Stage III.
Section 4
Evidence Appraisal
Primary Consensus
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
Cheson BD et al. • Journal of Clinical Oncology. 2014;32(27):3059-68.
The Lugano classification is the mid-2010s update to the classic Ann Arbor (1971) and Cotswolds (1989) systems, primarily integrating the role of PET imaging and simplifying bone marrow evaluation.